Silintan 25/pills Recall
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
What is the FDA recall status?
The FDA record lists this recall as ongoing. FDA enforcement data is not a live recall-lifecycle tracker. Follow the official instructions and check the agency notice or firm for current guidance.
Why was Silintan 25/pills recalled?
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
What should I do if I have this product?
Follow the firm and FDA instructions for the affected product. Contact the recalling firm for current guidance.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare your product with the product description and available lot, UPC or model codes below from the official FDA record to check whether it is covered by this recall. If an identifier is missing or unclear, check the complete official notice or contact the firm; an incomplete match here does not establish that your product is unaffected.
Full product description
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
Which lot codes, UPCs or models are affected?
All lots within expiry
- Agency record number
- D-0388-2026
- Product
- SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
- Recalling firm
- ANTHONY TRINH, 123Herbals LLC
- Quantity
- N/A
- Distribution
- USA nationwide
- Recall started
- October 20, 2025
- Report date
- March 11, 2026
- Classification
- Class I
- Status
- Ongoing
- Agency
- FDA (drug)